EUVIMEDEUVIMED entdecken
Crossref

Catalytical nanogels reprogram immunosuppressive metabolic networks for activatable cancer photo-immunotherapy

Mengting Yi, Mengyao Wu, Jianwei Zhang, Chang Xue, Congqiang Long, Lichang Zhang, Yilan Zhao, Fangxu Ning, Xuelei Hu, Chi Zhang

Journal of Controlled Release · 2026-11 · 399 · 115384

DOI: 10.1016/j.jconrel.2026.115384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2026-11. Verfasst von Mengting Yi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Hubei Engineering Research Center for Biomaterials and Medical Protective Material…. Hauptthemen laut MEDLINE: Immunotherapy, Photosensitizing Agents, Neoplasms, Nanogels. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Hubei Provincial Key Laboratory of Bioinorganic Chemistry and Materia Medica, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysregulation is a hallmark of cancer, making the modulation of these pathways an attractive therapeutic strategy; however, its clinical efficacy is often undermined by compensatory metabolic networks and inefficient tumor targeting effects. Here, we developed catalytical nanogels reprogramming immunosuppressive metabolic networks for activatable cancer photo-immunotherapy. The nanogels (abbreviated as OMST) were synthesized by crosslinking the oxidized hyaluronic acid with a methylthioadenosine (MTA)-catabolizing enzyme (methylthioadenosine phosphorylase: MTAP), an MTA-anabolism inhibitor (spermidine synthase inhibitor: SRMi), and the photosensitizer (TAPP) to form acid-cleavable imine bonds. Only in the acidic tumor microenvironment (TME), OMST was specifically disassociated to activate MTAP and SRMi, resulting in a synergistic two-side metabolic reprogramming for promoting MTA degradation and inhibiting its production, respectively. This two-side MTA depletion strategy reprogrammed the immunosuppressive TME, thus inhibiting protumorigenic M2 macrophages, promoting the antigen presentation of dendritic cells, and enhancing the proliferation of cytotoxic T lymphocytes. Upon localized photoirradiation, TAPP generated reactive oxygen species to induce immunogenic cell death, thereby synergizing with MTA metabolic reprogramming to reinvigorate antitumor immunity. Both in vitro and in vivo experiments demonstrated that OMST could effectively suppress tumor growth, metastasis, and recurrence. Thus, this study proposed a precise and multidimensional metabolic reprogramming strategy towards cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyPhotosensitizing AgentsNeoplasmsNanogelsAnimalsHumansMetabolic ReprogrammingTumor MicroenvironmentCell Line, TumorFemaleThionucleosidesMiceHyaluronic Acid

Stichwörter der Autor:innen

Cancer immunotherapyCancer phototherapyMetabolic reprogrammingNanogel

Substanzen

Photosensitizing AgentsNanogelsThionucleosidesHyaluronic Acid

Autor:innen und Institutionen

  • Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Hubei Engineering Research Center for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering, Huazhong University o…
  • Department of Medical Oncology, Tongji Medical College, Hubei Cancer Hospital, Huazhong University of Science and Technology, Wuhan 430079, Hubei, PR China.
  • Key Laboratory for Green Chemical Engineering Process of Ministry of Education, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, School of Chemical Engineering and Pharmacy, Wuhan Institute of Techno…

Förderung

  • Hubei Provincial Key Laboratory of Bioinorganic Chemistry and Materia Medica
  • National Natural Science Foundation of China

Zitieren

APA

Yi, M., Wu, M., Zhang, J., Xue, C., Long, C., Zhang, L., Zhao, Y., Ning, F., Hu, X., & Zhang, C. (2026). Catalytical nanogels reprogram immunosuppressive metabolic networks for activatable cancer photo-immunotherapy. Journal of Controlled Release, 399, 115384. https://doi.org/10.1016/j.jconrel.2026.115384

Vancouver

Yi M, Wu M, Zhang J, Xue C, Long C, Zhang L, et al. Catalytical nanogels reprogram immunosuppressive metabolic networks for activatable cancer photo-immunotherapy. Journal of Controlled Release. 2026;399:115384. doi:10.1016/j.jconrel.2026.115384

BibTeX
@article{Yi2026,
  author = {Yi, Mengting and Wu, Mengyao and Zhang, Jianwei and Xue, Chang and Long, Congqiang and Zhang, Lichang and Zhao, Yilan and Ning, Fangxu and Hu, Xuelei and Zhang, Chi},
  title = {Catalytical nanogels reprogram immunosuppressive metabolic networks for activatable cancer photo-immunotherapy},
  journal = {Journal of Controlled Release},
  year = {2026},
  volume = {399},
  pages = {115384},
  doi = {10.1016/j.jconrel.2026.115384}
}
Kostenlos starten →